Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

Exclusion Criteria

• •1. Patients who are contraindicated in the use of heparin, aspirin, clopidogrel, sirolimus, cobalt chromium and contrast agents
• •2. Patients who are pregnant or planning to become pregnant
• •3. Patients with a planned surgery to discontinue antiplatelet agents within 12 months
• •4. Patients with a life expectancy of less than 1 year
• •5. Patient with cardiogenic shock at the time of hospitalization and had a low chance of survival based on medical judgment.
• •6. Patients who have already received treatment with another DES (Drug Eluting Stent) or BMS (Bare Metal Stent) at the time of registration
• •7. Patients participating in randomized controlled trials using other medical devices